Precipitated κ-opioid receptor agonist withdrawal increases glutamate in rat locus coeruleus

European Journal of Pharmacology

Volumn 314, Issue 3, 1996, Pages 301-306

  Hoshi, Katsuji ^a   Ma, Tangeng ^a   Ho, Ing K ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Opioid receptor agonist; Butorphanol; Glutamate; Locus caeruleus; Microdialysis; U 69,593

Indexed keywords

ASPARTIC ACID; BUTORPHANOL; EXCITATORY AMINO ACID; GLUTAMIC ACID; KAPPA OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE;

ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG WITHDRAWAL; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCUS CERULEUS; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; ASPARTIC ACID; BENZENEACETAMIDES; BUTORPHANOL; GLUTAMIC ACID; INJECTIONS, INTRAVENTRICULAR; LOCUS COERULEUS; MALE; MICRODIALYSIS; NALOXONE; NARCOTIC ANTAGONISTS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030608348     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00569-9     Document Type: Article

References (23)

1. Aghajanian, G.K., 1978, Tolerance of locus coeruleus neurons to morphine and suppression of withdrawal response by clonidine, Nature 276, 186.
2. Aghajanian, G.K., J.H. Kogan and B. Moghaddam, 1994, Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study, Brain Res. 636, 126.
3. Akaoka, H. and G. Aston-Jones, 1991, Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input, J. Neurosci. 11, 3830.
4. Aston-Jones, G., M. Ennis, V.A. Pieribone, W.T. Nickell and M.T. Shipley, 1986, The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network, Science 234, 734.
5. Atweh, S.F. and M.J. Kuhar, 1977, Autoradiographic localization of opioid receptors in rat brain. II. The brain stem, Brain Res. 129, 1.
6. Barro, M., F. Ruiz and M.A. Hurle, 1995, κ-Opioid receptor mediated antinociception in rats is dependent on the functional state of dihydropyridine-sensitive calcium channels, Brain Res. 672, 148.
7. Butelman, E.R., G. Winger, G. Zernig and J.H. Woods, 1995, Butorphanol: characterization of agonist and antagonist effects in rhesus monkeys, J. Pharmacol. Exp. Ther. 272, 845.
8. Crowder, J.M., D.K. Norris and H.F. Bradford, 1986, Morphine inhibition of calcium fluxes, neurotransmitter release and protein and lipid phosphorylation in brain slices and synaptosomes, Biochem. Pharmacol. 35, 2501.
9. Ellison, D.W., M.F. Beal and J.B. Martin, 1987, Amino acid neurotransmitters in postmortem human brain analyzed by high performance liquid chromatography with electrochemical detection, J. Neurosci. Methods 19, 305.
10. Feng, Y.Z., T. Zhang, R.W. Rockhold and I.K. Ho, 1995, Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat, Neurochem. Res. 20, 745.
11. Horan, P. and I.K. Ho, 1991, The physical dependence liability of butorphanol: a comparative study with morphine, Eur. J. Pharmacol. 203, 387.
12. Maldonado, R., L. Stinus, L.H. Gold and G.F. Koob, 1992, Role of different brain structures in the expression of the physical morphine withdrawal syndrome, J. Pharmacol. Exp. Ther. 261, 669.
13. Mosaddeghi, M., D.R. Kapusta, L.D. Minor, N. Duan and D. Paul, 1995, Effects of κ-opioid receptor agonists on stimulated phosphoinositide hydrolysis in rat kidney, Eur. J. Pharmacol. 289, 411.
14. Olsson, Y., H.S. Sharma, F. Nyberg and J. Westman, 1995, The opioid receptor antagonist naloxone influences the pathophysiology of spinal cord injury, in: Progress in Brain Research. Vol. 104, eds. F. Nyberg, H.S. Sharma and Z. Wiesenfeld-Hallin (Elsevier, Amsterdam) p. 381.
15. Pasternak, G.W., 1993, Review: pharmacological mechanisms of opioid analgesics, Clin. Neuropharmacol. 16, 1.
16. Paxinos, G. and C. Watson, 1986, The Rat Brain In Stereotaxic Coordinates, 2nd Ed. (Academic Press, Orlando, FL).
17. Preston, K.L., G.E. Bigelow and I.A. Liebson, 1988, Butorphanol-precipitated withdrawal in opioid-dependent human volunteers, J. Pharmacol. Exp. Ther. 246, 441.
18. Rasmussen, K., 1991, Afferent effects on locus coeruleus in opiate withdrawal, in: Progress in Brain Research, Vol. 88, eds. C.D. Barnes and O. Pompeiano (Elsevier, Amsterdam) p. 207.
19. Rasmussen, K. and G.K. Aghajanian, 1989, Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis, Brain Res. 505, 346.
20. Rasmussen, K., D.B. Beitner-Johnson, J.H. Krystal, G.K. Aghajanian and E.J. Nestler, 1990, Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates, J. Neurosci. 10, 2308.
21. Rasmussen, K., J.H. Krystal and G.K. Aghajanian, 1991, Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration, Psychopharmacology 105, 508.
22. Yasuda, K., K. Raynor, H. Kong, C.D. Breder, J. Takeda, T. Reisine and G.I. Bell, 1993, Cloning and functional comparison of κ and δ opioid receptors from mouse brain, Proc. Natl. Acad. Sci. USA 90, 6736.
23. Zhang, T., Y. Feng, R.W. Rockhold and I.K. Ho, 1994, Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat, Life Sci. 55, PL25.